Arbutus Biopharma Corp ABUS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/10/24 EDT
2.88quote price arrow down-0.06 (-2.04%)
Volume
678,599
52 week range
1.69 - 3.29
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.88
  • 52 Week High3.29
  • 52 Week High Date04/05/24
  • 52 Week Low1.69
  • 52 Week Low Date10/24/23

Key Stats

  • Market Cap543.506M
  • Shares Out188.72M
  • 10 Day Average Volume0.72M
  • Dividend-
  • Dividend Yield-
  • Beta1.95
  • YTD % Change15.2

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.88
  • 52 Week High3.29
  • 52 Week High Date04/05/24
  • 52 Week Low1.69
  • 52 Week Low Date10/24/23
  • Market Cap543.506M
  • Shares Out188.72M
  • 10 Day Average Volume0.72M
  • Dividend-
  • Dividend Yield-
  • Beta1.95
  • YTD % Change15.2

RATIOS/PROFITABILITY

  • EPS (TTM)-0.44
  • P/E (TTM)-6.56
  • Fwd P/E (NTM)-7.22
  • EBITDA (TTM)-78.628M
  • ROE (TTM)-57.54%
  • Revenue (TTM)12.986M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-572.81%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Arbutus Biopharma Corp

 

Profile

MORE
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is leveraging its virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can potentially be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV) infection. Its HBV product pipeline includes Imdusiran and AB-101. Imdusiran is its proprietary, conjugated GalNAc, subcutaneously delivered RNAi therapeutic...
Frank Torti M.D.
Independent Chairman of the Board
Michael Mcelhaugh
Interim President, Chief Executive Officer, Director
David Hastings
Chief Financial Officer
Elizabeth Howard J.D., Ph.D.
Executive Vice President, General Counsel, Chief Compliance Officer and Secretary
Address
701 Veterans Circle
Warminster, PA
18974
United States

Top Peers

SYMBOLLASTCHG%CHG
CYBN
Cybin Inc
0.3625-0.0113-3.023%
AUPH
Aurinia Pharmaceuticals Inc
5.02-0.15-2.90%
CRDL
Cardiol Therapeutics Inc
2.14-0.07-3.17%
MDNA
Medicenna Therapeutics Corp
2.47UNCHUNCH
DMAC
DiaMedica Therapeutics Inc
3.12-0.13-4.00%